User Stats
| Total reviews: | 6 |
| Level: | Guru |
| Member Since: | 04/12/2018 |
Profile Information
| First name | Maria |
| Last name | Eugenia RIveiro |
Biotech, Cancer therapeutics, Clinical trials, Drug Discovery, Medicine, Nanotechnology, Oncology, Personalised medicine, Therapeutics, Regulatory
I have over 15 years of experience working in preclinical drug development, I led the preclinical development seed phase of 13 novel leads, covering small molecules and monoclonal antibodies. I am specialized in molecular pharmacology assessments, PK/ADME and CMC regulatory compliance and intellectual property rights in biotechnology companies.
Currently, as E2DG’s Chief Scientific Officer, I support our clients and collaborators to optimize and accelerate their R&D programs in oncology. E2DG offers professional assistance all along the drug development life cycle, from lead optimization to Phase I clinical trials in oncology.
